Literature DB >> 18197035

Langerhans cell histiocytosis: update for the pediatrician.

Sheila Weitzman1, R Maarten Egeler.   

Abstract

PURPOSE OF REVIEW: Langerhans cell histiocytosis is the commonest of the histiocytic disorders. Owing to the relative rarity of the condition, it remains a disease in which the diagnosis is often delayed or missed and in which many questions remain unanswered, ranging from etiology and pathogenesis to therapy. The management is often frustrating for care-givers and parents/patients. The purpose of the review is therefore to raise awareness of the disease and to highlight the clinical findings that should make the pediatrician or primary care-giver suspect the diagnosis, as well as current thinking regarding management of the various and diverse manifestations of this disease. RECENT
FINDINGS: We discuss new and interesting insights into the biology of Langerhans cell histiocytosis that raise the possibility of future targeted therapy. Important points in the diagnosis, investigation and management of the various forms of the disease are also discussed.
SUMMARY: We present a review of childhood Langerhans cell histiocytosis, highlighting new insights into pathogenesis and management of the various forms of this complex disease.

Entities:  

Mesh:

Year:  2008        PMID: 18197035     DOI: 10.1097/MOP.0b013e3282f45ba4

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  40 in total

Review 1.  Necrotizing infundibuloneurohypophysitis: case report and literature review.

Authors:  Anick Nater; Luis V Syro; Fabio Rotondo; Bernd W Scheithauer; Veronica Abad; Carolina Jaramillo; Kalman Kovacs; Eva Horvath; Michael Cusimano
Journal:  Endocr Pathol       Date:  2012-09       Impact factor: 3.943

Review 2.  18F-Fluorodeoxyglucose PET/CT in Langerhans cell histiocytosis: spectrum of manifestations.

Authors:  Krishan Kant Agarwal; Rachna Seth; Abhishek Behra; Manisha Jana; Rakesh Kumar
Journal:  Jpn J Radiol       Date:  2016-01-13       Impact factor: 2.374

3.  Role of 18F-FDG PET/CT in patients affected by Langerhans cell histiocytosis.

Authors:  Domenico Albano; Giovanni Bosio; Raffaele Giubbini; Francesco Bertagna
Journal:  Jpn J Radiol       Date:  2017-07-26       Impact factor: 2.374

4.  Congenital self-healing reticulohistiocytosis.

Authors:  Young H Lee; Mala K Talekar; Catherine G Chung; Moshe D Bell; Andrea L Zaenglein
Journal:  J Clin Aesthet Dermatol       Date:  2014-02

5.  Does adjunctive chemotherapy reduce remission rates compared to cortisone alone in unifocal or multifocal histiocytosis of bone?

Authors:  André Mathias Baptista; André Ferrari França Camargo; Olavo Pires de Camargo; Vicente Odone Filho; Alejandro Enzo Cassone
Journal:  Clin Orthop Relat Res       Date:  2012-03       Impact factor: 4.176

6.  Langerhans cell histiocytosis in a pediatric HIV patient.

Authors:  Rachna Seth; Panneer Selvam; Richa Jain; Ranajoy Gosh; Jenish Arun; Rakesh Lodha
Journal:  Virusdisease       Date:  2015-07-28

7.  Ninety-year-old man with hypereosinophilia, lymphadenopathies and pruritus.

Authors:  José Guilherme Freitas; Ana Jorge; Daniel Rei; Joana Graça
Journal:  BMJ Case Rep       Date:  2018-01-10

Review 8.  Interstitial lung diseases in children.

Authors:  Annick Clement; Nadia Nathan; Ralph Epaud; Brigitte Fauroux; Harriet Corvol
Journal:  Orphanet J Rare Dis       Date:  2010-08-20       Impact factor: 4.123

9.  Hepatic involvement of Langerhans cell histiocytosis in children--imaging findings of computed tomography, magnetic resonance imaging and magnetic resonance cholangiopancreatography.

Authors:  Yingyan Shi; Zhongwei Qiao; Chunmei Xia; Ying Gong; Haowei Yang; Guoping Li; Mier Pa
Journal:  Pediatr Radiol       Date:  2014-02-28

Review 10.  The child with bone pain: malignancies and mimickers.

Authors:  M Beth McCarville
Journal:  Cancer Imaging       Date:  2009-10-02       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.